281 related articles for article (PubMed ID: 26082997)
1. Stimulation of PAR-1 or PAR-4 promotes similar pattern of VEGF and endostatin release and pro-angiogenic responses mediated by human platelets.
Etulain J; Mena HA; Negrotto S; Schattner M
Platelets; 2015; 26(8):799-804. PubMed ID: 26082997
[TBL] [Abstract][Full Text] [Related]
2. The effect of P2Y-mediated platelet activation on the release of VEGF and endostatin from platelets.
Bambace NM; Levis JE; Holmes CE
Platelets; 2010; 21(2):85-93. PubMed ID: 20063989
[TBL] [Abstract][Full Text] [Related]
3. Quantitative proteomics analysis reveals similar release profiles following specific PAR-1 or PAR-4 stimulation of platelets.
van Holten TC; Bleijerveld OB; Wijten P; de Groot PG; Heck AJ; Barendrecht AD; Merkx TH; Scholten A; Roest M
Cardiovasc Res; 2014 Jul; 103(1):140-6. PubMed ID: 24776597
[TBL] [Abstract][Full Text] [Related]
4. Differential Effects of Platelets Selectively Activated by Protease-Activated Receptors on Meniscal Cells.
Xu H; Zou X; Xia P; Aboudi MAK; Chen R; Huang H
Am J Sports Med; 2020 Jan; 48(1):197-209. PubMed ID: 31765237
[TBL] [Abstract][Full Text] [Related]
5. Proteinase-activated receptors 1 and 4 counter-regulate endostatin and VEGF release from human platelets.
Ma L; Perini R; McKnight W; Dicay M; Klein A; Hollenberg MD; Wallace JL
Proc Natl Acad Sci U S A; 2005 Jan; 102(1):216-20. PubMed ID: 15615851
[TBL] [Abstract][Full Text] [Related]
6. Platelet-mediated angiogenesis is independent of VEGF and fully inhibited by aspirin.
Etulain J; Fondevila C; Negrotto S; Schattner M
Br J Pharmacol; 2013 Sep; 170(2):255-65. PubMed ID: 23713888
[TBL] [Abstract][Full Text] [Related]
7. PAR1-stimulated platelet releasate promotes angiogenic activities of endothelial progenitor cells more potently than PAR4-stimulated platelet releasate.
Huang Z; Miao X; Luan Y; Zhu L; Kong F; Lu Q; Pernow J; Nilsson G; Li N
J Thromb Haemost; 2015 Mar; 13(3):465-76. PubMed ID: 25495701
[TBL] [Abstract][Full Text] [Related]
8. The role of thrombin receptors PAR1 and PAR4 for PAI-1 storage, synthesis and secretion by human platelets.
Nylander M; Osman A; Ramström S; Aklint E; Larsson A; Lindahl TL
Thromb Res; 2012 Apr; 129(4):e51-8. PubMed ID: 22283974
[TBL] [Abstract][Full Text] [Related]
9. Distinct platelet packaging, release, and surface expression of proangiogenic and antiangiogenic factors on different platelet stimuli.
Chatterjee M; Huang Z; Zhang W; Jiang L; Hultenby K; Zhu L; Hu H; Nilsson GP; Li N
Blood; 2011 Apr; 117(14):3907-11. PubMed ID: 21330475
[TBL] [Abstract][Full Text] [Related]
10. Platelet releasate promotes breast cancer growth and angiogenesis via VEGF-integrin cooperative signalling.
Jiang L; Luan Y; Miao X; Sun C; Li K; Huang Z; Xu D; Zhang M; Kong F; Li N
Br J Cancer; 2017 Aug; 117(5):695-703. PubMed ID: 28697175
[TBL] [Abstract][Full Text] [Related]
11. Control of angiogenesis by galectins involves the release of platelet-derived proangiogenic factors.
Etulain J; Negrotto S; Tribulatti MV; Croci DO; Carabelli J; Campetella O; Rabinovich GA; Schattner M
PLoS One; 2014; 9(4):e96402. PubMed ID: 24788652
[TBL] [Abstract][Full Text] [Related]
12. Platelets modulate gastric ulcer healing: role of endostatin and vascular endothelial growth factor release.
Ma L; Elliott SN; Cirino G; Buret A; Ignarro LJ; Wallace JL
Proc Natl Acad Sci U S A; 2001 May; 98(11):6470-5. PubMed ID: 11353854
[TBL] [Abstract][Full Text] [Related]
13. Specific activation, signalling and secretion profiles of human platelets following PAR-1 and PAR-4 stimulation.
Nguyen KA; Hamzeh-Cognasse H; Laradi S; Pozzetto B; Garraud O; Cognasse F
Platelets; 2015; 26(8):795-8. PubMed ID: 26083907
[TBL] [Abstract][Full Text] [Related]
14. Release of angiogenesis regulatory proteins from platelet alpha granules: modulation of physiologic and pathologic angiogenesis.
Battinelli EM; Markens BA; Italiano JE
Blood; 2011 Aug; 118(5):1359-69. PubMed ID: 21680800
[TBL] [Abstract][Full Text] [Related]
15. Thrombin-induced platelet endostatin release is blocked by a proteinase activated receptor-4 (PAR4) antagonist.
Ma L; Hollenberg MD; Wallace JL
Br J Pharmacol; 2001 Oct; 134(4):701-4. PubMed ID: 11606309
[TBL] [Abstract][Full Text] [Related]
16. Regulation of protease-activated receptor (PAR) 1 and PAR4 signaling in human platelets by compartmentalized cyclic nucleotide actions.
Bilodeau ML; Hamm HE
J Pharmacol Exp Ther; 2007 Aug; 322(2):778-88. PubMed ID: 17525299
[TBL] [Abstract][Full Text] [Related]
17. Platelets accelerate gastric ulcer healing through presentation of vascular endothelial growth factor.
Wallace JL; Dicay M; McKnight W; Dudar GK
Br J Pharmacol; 2006 Jun; 148(3):274-8. PubMed ID: 16565732
[TBL] [Abstract][Full Text] [Related]
18. Tamoxifen and aromatase inhibitors differentially affect vascular endothelial growth factor and endostatin levels in women with breast cancer.
Holmes CE; Huang JC; Pace TR; Howard AB; Muss HB
Clin Cancer Res; 2008 May; 14(10):3070-6. PubMed ID: 18483373
[TBL] [Abstract][Full Text] [Related]
19. Platelet-rich plasma stimulated by pulse electric fields: Platelet activation, procoagulant markers, growth factor release and cell proliferation.
Frelinger AL; Torres AS; Caiafa A; Morton CA; Berny-Lang MA; Gerrits AJ; Carmichael SL; Neculaes VB; Michelson AD
Platelets; 2016; 27(2):128-35. PubMed ID: 26030682
[TBL] [Abstract][Full Text] [Related]
20. Modification of Pulsed Electric Field Conditions Results in Distinct Activation Profiles of Platelet-Rich Plasma.
Frelinger AL; Gerrits AJ; Garner AL; Torres AS; Caiafa A; Morton CA; Berny-Lang MA; Carmichael SL; Neculaes VB; Michelson AD
PLoS One; 2016; 11(8):e0160933. PubMed ID: 27556645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
